In conclusion, despite the limitations, our meta-analysis indicates a predictive role for the genetic polymorphisms of XRCC1 gene in clinical outcomes of platinum-based chemotherapy for advanced lung cancer patients. The gene discussed is XRCC1; the disease is lung carcinoma.